x

Lexeo Therapeutics, Inc. (Nasdaq:LXEO)

Health Care/Life Sciences • Biotechnology
CIK 1907108
Company

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.

Address
345 Park Avenue South
6th floor
New York, New York 10010
Employees
58
Stock Info
Close
$2.7100
Day Range
2.4650 - 2.7200
52 Week Range
2.3200 - 19.5000
Average volume
319.02K
Short Interest
2.31M (02/14/25)
% of Float Shorted
9.27%
Market Cap
$89.61M
Revenue
N/A
Net Income
-$66.39M
2020 Sales Growth
N/A
Rev. per Employee
N/A
P/E Ratio
N/A
EPS
-$2.8428
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Director
Tolga Tanguler
Chairman
Steven M. Altschuler
Independent Director
Mette Kirstine Agger
Independent Director
Brenda Cooperstone
Independent Director
Reinaldo M. Diaz
Independent Non-Executive Director
Tim van Hauwermeiren
Independent Director
Paula H. J. Cholmondeley
SEC filings
DateFormEvent
19 Dec, 2024 EFFECT
19 Dec, 2024 8-K
13 Dec, 2024 S-3
12 Dec, 2024 4
10 Dec, 2024 144
3 Dec, 2024 EFFECT
2 Dec, 2024 POS AM
26 Nov, 2024 4
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
14 Nov, 2024 SC 13G/A
13 Nov, 2024 10-Q
13 Nov, 2024 424B3
13 Nov, 2024 8-K
13 Nov, 2024 424B3
13 Nov, 2024 4
13 Nov, 2024 4
13 Nov, 2024 3
12 Nov, 2024 SC 13G
30 Oct, 2024 8-K
30 Oct, 2024 424B3
15 Oct, 2024 4
9 Oct, 2024 8-K
9 Oct, 2024 424B3
11 Sep, 2024 4
10 Sep, 2024 144
13 Aug, 2024 4
12 Aug, 2024 424B3
12 Aug, 2024 8-K
12 Aug, 2024 10-Q
9 Aug, 2024 SC 13G/A
5 Aug, 2024 SC 13G/A
15 Jul, 2024 424B3
15 Jul, 2024 8-K
12 Jul, 2024 4
8 Jul, 2024 4
8 Jul, 2024 8-K
8 Jul, 2024 424B3
8 Jul, 2024 3
28 Jun, 2024 424B3
28 Jun, 2024 8-K
27 Jun, 2024 4
27 Jun, 2024 4
27 Jun, 2024 4
27 Jun, 2024 4
27 Jun, 2024 4
14 Jun, 2024 4
12 Jun, 2024 4
22 May, 2024 3
14 May, 2024 4
13 May, 2024 144
9 May, 2024 10-Q
9 May, 2024 424B3
9 May, 2024 8-K
26 Apr, 2024 ARS
26 Apr, 2024 DEF 14A
26 Apr, 2024 DEFA14A
22 Apr, 2024 424B3
22 Apr, 2024 8-K
22 Apr, 2024 424B3
22 Apr, 2024 8-K
16 Apr, 2024 8-K
16 Apr, 2024 424B3
12 Apr, 2024 424B3
12 Apr, 2024 EFFECT
11 Apr, 2024 CORRESP
11 Apr, 2024 UPLOAD
9 Apr, 2024 S-1
11 Mar, 2024 S-8
11 Mar, 2024 10-K
11 Mar, 2024 8-K
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G/A
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
14 Feb, 2024 SC 13G
13 Feb, 2024 SC 13G
6 Feb, 2024 4
6 Feb, 2024 4
6 Feb, 2024 4
6 Feb, 2024 3
5 Feb, 2024 8-K
9 Jan, 2024 4
9 Jan, 2024 4
18 Dec, 2023 8-K
15 Dec, 2023 SC 13G/A
11 Dec, 2023 SC 13G
11 Dec, 2023 10-Q
11 Dec, 2023 8-K
24 Nov, 2023 SC 13G
17 Nov, 2023 SC 13G
9 Nov, 2023 4
9 Nov, 2023 4
9 Nov, 2023 4
9 Nov, 2023 4
7 Nov, 2023 S-8
7 Nov, 2023 8-K
6 Nov, 2023 SEC STAFF
6 Nov, 2023 424B4 IPO completed
3 Nov, 2023 FWP
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 3
2 Nov, 2023 CERT
2 Nov, 2023 EFFECT
2 Nov, 2023 3
1 Nov, 2023 8-A12B
1 Nov, 2023 CORRESP
1 Nov, 2023 S-1/A
1 Nov, 2023 UPLOAD
31 Oct, 2023 CORRESP
31 Oct, 2023 CORRESP
30 Oct, 2023 S-1/A
5 Oct, 2023 CORRESP
29 Sep, 2023 S-1
19 Sep, 2023 SEC STAFF
18 Sep, 2023 DRSLTR
18 Sep, 2023 DRS/A
18 Aug, 2023 UPLOAD
16 Aug, 2023 DRS/A
15 Aug, 2023 DRSLTR
13 Jun, 2023 UPLOAD
17 May, 2023 DRS/A
17 May, 2023 DRSLTR
17 May, 2022 UPLOAD
5 May, 2022 DRSLTR
5 May, 2022 DRS/A
3 Mar, 2022 UPLOAD
4 Feb, 2022 DRS
Last update:2025-03-06 12:15:09.376498
Lexeo Therapeutics, Inc. by TradingView

Sign Up to Subscribe